The increasing focus on rare disease treatment and targeted biologic therapies has accelerated advancements in C1 esterase inhibitor, angioedema treatment, and complement inhibitor therapy. These innovative therapeutic approaches are transforming the management of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling caused by uncontrolled...